Target intelligence / Profile preview

Synaptic Vesicle Glycoprotein 2B (SV2B)

Target
SV2B
Molecular classification
Synaptic Vesicle Glycoprotein, Transporter
01

Overview

Synaptic vesicle glycoprotein 2B (SV2B) is a member of the SV2 protein family, integral membrane proteins found on synaptic vesicles in neurons. SV2B is critical for proper neurotransmission, playing roles in the regulation of synaptic vesicle exocytosis and neurotransmitter release. It interacts with other synaptic vesicle proteins like synaptotagmin and may act as a master regulator of vesicular structure. While most clinical focus has been on its paralog SV2A, emerging evidence implicates SV2B in neurodegenerative diseases. Recent structural studies suggest that anticonvulsants bind a conserved central site shared among all three paralogs including SV2B; this provides a blueprint for future drug design targeting this family.

02

Mechanism of action

Modulation of synaptic vesicle exocytosis by binding to SV2 proteins

03

Biological functions

Regulated secretion/exocytosisNeurotransmitter release regulationSynaptic vesicle traffickingStabilizes transmitter content
04

Disease associations

Alzheimer's diseaseParkinson's diseaseNeurodegenerative disease
05

Interacting drugs

Levetiracetam

1 more in the full profile.

Beyond the preview

Go deeper on Synaptic Vesicle Glycoprotein 2B (SV2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptic Vesicle Glycoprotein 2B (SV2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call